CJC-1295 mastery course
Unit 9 of 12
Product quality & regulation
CJC-1295 carries a safety issue most peptides do not: because the DAC and no-DAC versions differ in dose by roughly ten…
The label problem, and the legal reality
CJC-1295 carries a safety issue most peptides do not: because the DAC and no-DAC versions differ in dose by roughly tenfold, a mislabeled vial can expose someone to far more, or far less, than they intend. On top of that, CJC-1295 is not an approved medicine anywhere, and it is banned in sport.
This unit covers the two things a careful reader most needs: how to think about product identity and quality in an unregulated market, and exactly where CJC-1295 stands legally with the FDA and the anti-doping system. Both are about protecting yourself from confident claims that do not hold up.